Company Profile · Healthcare

Sartorius Aktiengesellschaft

SRT3 · XETRA
Exchange
XETRA
Country
Germany
Employees
14,242
Current Price
213
Live · Jun 20, 2026
Fair Buy
≤ €188
Margin-of-safety entry
Baillie Growth Score
51/100
Medium
Intrinsic Value · Three-Tier Range Current price €213 Live · Within the fair intrinsic-value range

Composite valuation range · conservative €170–€188 / fair €204–€276 / optimistic €292–€320. At €213, Within the fair intrinsic-value range.

At publication €217.1 (Jun 19, 2026)

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products. It also provides lab filtration and purification solutions, lab water purification systems, microtissue technologies, lab weighing, pipettes, tips and dispensers, microbiological testing solutions, lab data and fleet management software, and OEM solutions; and Process chromatography and filtration solutions. The company serves the life science research, biopharmaceutical manufacturing, cell and gene therapy, and applied industries. The company was founded in 1870 and is headquartered in Göttingen, Germany.

Market cap€16.03B
Revenue (TTM)€3.55B
EBITDA€905.5M
Profit margin4.58%
ROE6.18%
P/E (TTM)98.39
Forward P/E42.02
PEG0.94
EPS€2.36
Dividend yield0.32%
52-week range€175.35 – €266.78

Data from EODHD, shown in the reporting currency; for reference only, not investment advice.

History

Coming soonThis section is being filled in — check back soon.

Industry position

Coming soonThis section is being filled in — check back soon.